Follow
Penelope A Turner
Penelope A Turner
Evotec
No verified email
Title
Cited by
Cited by
Year
Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis
Y Park, A Pacitto, T Bayliss, LAT Cleghorn, Z Wang, T Hartman, K Arora, ...
ACS infectious diseases 3 (1), 18-33, 2017
852017
Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB
LAT Cleghorn, PC Ray, J Odingo, A Kumar, H Wescott, A Korkegian, ...
Journal of Medicinal Chemistry 61 (15), 6592-6608, 2018
562018
Tetrahydroxanthones by sequential Pd-catalyzed C− O and C− C bond construction and use in the identification of the “antiausterity” pharmacophore of the kigamicins
PA Turner, EM Griffin, JL Whatmore, M Shipman
Organic Letters 13 (5), 1056-1059, 2011
502011
Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth
PC Ray, M Huggett, PA Turner, M Taylor, LAT Cleghorn, J Early, A Kumar, ...
ACS omega 6 (3), 2284-2311, 2021
192021
New strategies for the synthesis and functionalization of tetrahydroxanthones
PA Turner, JV Geden, A White, GJ Clarkson, M Shipman
Tetrahedron 71 (50), 9433-9438, 2015
62015
Stereocontrolled synthesis of a d-amicetose functionalised tetrahydroxanthone related to kigamicin A
PA Turner, JL Whatmore, M Shipman
Tetrahedron Letters 54 (48), 6538-6540, 2013
32013
Biologically active kigamicin analogues by sequential palladium catalysed CO and CC bond construction
PA Turner
University of Warwick, 2012
12012
Biologically active tetrahydroxanthones by sequential Pd-catalyzed CO and CC bond construction
PA Turner, EM Griffin, JL Whatmore, M Shipman
American Chemical Society. Abstracts of Papers (at the National Meeting) 242 …, 2011
2011
A high temperature in pulmonary tuberculosis with eventual arrest of the disease: a case report
PA TURNER
North Carolina medical journal 8 (11), 717-719, 1947
1947
The system can't perform the operation now. Try again later.
Articles 1–9